The aim of this study was to assess the safety and feasibility of macroscopically complete (R0) secondary debulking surgery (SDS) in a single-center cohort of patients with recurrent ovarian cancer. The performances of existing prediction models (DESKTOP score, Tian model) for R0 SDS were evaluated in this cohort.status: publishe
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
The most advanced epithelial ovarian cancer develops recurrent disease despite maximal surgical cyto...
The aim of this study was to assess the safety and feasibility of macroscopically complete (R0) seco...
OBJECTIVE: The purpose of this study was to validate the performance of two prediction models, the A...
Contains fulltext : 155248.pdf (publisher's version ) (Closed access)OBJECTIVE: Th...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
The most advanced epithelial ovarian cancer develops recurrent disease despite maximal surgical cyto...
The aim of this study was to assess the safety and feasibility of macroscopically complete (R0) seco...
OBJECTIVE: The purpose of this study was to validate the performance of two prediction models, the A...
Contains fulltext : 155248.pdf (publisher's version ) (Closed access)OBJECTIVE: Th...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
Objective. The purpose of this study was to validate the performance of two prediction models, the A...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
ObjectiveOptimal debulking with no macroscopic residual disease strongly predicts ovarian cancer sur...
The most advanced epithelial ovarian cancer develops recurrent disease despite maximal surgical cyto...